Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jiangxia Du"'
Publikováno v:
Sensors, Vol 19, Iss 4, p 968 (2019)
Ultra high frequency radio frequency identification (UHF RFID)-based indoor localization technology has been a competitive candidate for context-awareness services. Previous works mainly utilize a simplified Friis transmission equation for simulating
Externí odkaz:
https://doaj.org/article/32759fa806664686902b1fcf5763f7f2
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 17:1311-1325
INTRODUCTION By 1 January 2021, the FDA has approved a total of 62 small-molecule kinase inhibitors (SMKIs). The increasing clinical use of small-molecule kinase inhibitors has led to some side effects, the most common of which is cutaneous toxicity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0850dd86fa25c1a5639a11c44d0f64af
https://doi.org/10.1080/17425255.2021.2004116
https://doi.org/10.1080/17425255.2021.2004116
Autor:
Ying Jin, Zhifei Xu, Jinjin Shao, Peihua Luo, Qiaojun He, Nengming Lin, Ying Zhang, Bo Yang, Hao Yan, Jiangxia Du, Xueqin Chen
Publikováno v:
Autophagy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Liver dysfunction is an outstanding dose-limiting toxicity of gefitinib, an EGFR (epidermal growth factor receptor)-tyrosine kinase inhibitor (TKI), in the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). We aimed to elucidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9f5b3a3fe3f9d2f82c29313a045049
https://doi.org/10.1080/15548627.2020.1851492
https://doi.org/10.1080/15548627.2020.1851492
Autor:
Ying Jin, Jiangxia Du, Ziying Zhao, Bo Yang, Liyu Jiang, Fuquan Jin, Peihua Luo, Qiaojun He, Ying Zhang
Publikováno v:
European Journal of Pharmacology. 847:26-31
Renal fibrosis is the common final outcome of nearly all progressive chronic kidney diseases (CKD) that eventually develop into end-stage renal failure, which threatens the lives of patients. Currently, there are no effective drugs for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4121c25c767eda54e97d9f1e9ebe6445
https://doi.org/10.1016/j.ejphar.2019.01.012
https://doi.org/10.1016/j.ejphar.2019.01.012
Autor:
Xiaochen Zhang, Xiaochun Yang, Liyu Jiang, Jiangxia Du, Guanqun Li, Ziye Zhou, Zhifei Xu, Hao Yan, Peihua Luo, Qiaojun He
Publikováno v:
Toxicology letters. 338
Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic or advanced non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations. Pulmonary t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d75ac78f1b35a2b96e60a313c2987aa
https://pubmed.ncbi.nlm.nih.gov/33248157
https://pubmed.ncbi.nlm.nih.gov/33248157
Autor:
Ying Zhang, Ji Cao, Zhifei Xu, Ziying Zhao, Xiaochen Zhang, Su Zeng, Hao Yan, Bo Yang, Qiaojun He, Shenglin Ma, Peihua Luo, Jiangxia Du, Xueqin Chen, Yi Zhu
Publikováno v:
Cell Research
Hand–foot skin reaction (HFSR), among the most significant adverse effects of sorafenib, has been limiting the clinical benefits of this frontline drug in treating various malignant tumors. The mechanism underlying such toxicity remains poorly unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50cd5ab25e9f5cc7ff4189c5667ff482
https://pubmed.ncbi.nlm.nih.gov/32296111
https://pubmed.ncbi.nlm.nih.gov/32296111
Publikováno v:
Toxicology and applied pharmacology. 383
Crizotinib is an oral small-molecule tyrosine kinase inhibitor targeting anaplastic lymphoma kinase (ALK), ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) and MET proto-oncogene, receptor tyrosine kinase (MET). Unfortunately, hepatotoxicity is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5dcfe89a0f49573f92a64ea53a93b90
https://pubmed.ncbi.nlm.nih.gov/31639374
https://pubmed.ncbi.nlm.nih.gov/31639374
Publikováno v:
Sensors (Basel, Switzerland)
Ultra high frequency radio frequency identification (UHF RFID)-based indoor localization technology has been a competitive candidate for context-awareness services. Previous works mainly utilize a simplified Friis transmission equation for simulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b253971e5748a569c4efa8a14a486f9c
https://pubmed.ncbi.nlm.nih.gov/30823553
https://pubmed.ncbi.nlm.nih.gov/30823553